187 related articles for article (PubMed ID: 24962566)
1. Forces and dynamics of glucose and inhibitor binding to sodium glucose co-transporter SGLT1 studied by single molecule force spectroscopy.
Neundlinger I; Puntheeranurak T; Wildling L; Rankl C; Wang LX; Gruber HJ; Kinne RK; Hinterdorfer P
J Biol Chem; 2014 Aug; 289(31):21673-83. PubMed ID: 24962566
[TBL] [Abstract][Full Text] [Related]
2. Ligands on the string: single-molecule AFM studies on the interaction of antibodies and substrates with the Na+-glucose co-transporter SGLT1 in living cells.
Puntheeranurak T; Wildling L; Gruber HJ; Kinne RK; Hinterdorfer P
J Cell Sci; 2006 Jul; 119(Pt 14):2960-7. PubMed ID: 16787940
[TBL] [Abstract][Full Text] [Related]
3. Substrate specificity of sugar transport by rabbit SGLT1: single-molecule atomic force microscopy versus transport studies.
Puntheeranurak T; Wimmer B; Castaneda F; Gruber HJ; Hinterdorfer P; Kinne RK
Biochemistry; 2007 Mar; 46(10):2797-804. PubMed ID: 17302432
[TBL] [Abstract][Full Text] [Related]
4. Three surface subdomains form the vestibule of the Na+/glucose cotransporter SGLT1.
Puntheeranurak T; Kasch M; Xia X; Hinterdorfer P; Kinne RK
J Biol Chem; 2007 Aug; 282(35):25222-30. PubMed ID: 17616521
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase-A affects sorting and conformation of the sodium-dependent glucose co-transporter SGLT1.
Subramanian S; Glitz P; Kipp H; Kinne RK; Castaneda F
J Cell Biochem; 2009 Feb; 106(3):444-52. PubMed ID: 19115253
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C mediated intracellular signaling pathways are involved in the regulation of sodium-dependent glucose co-transporter SGLT1 activity.
Castaneda-Sceppa C; Subramanian S; Castaneda F
J Cell Biochem; 2010 Apr; 109(6):1109-17. PubMed ID: 20069550
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel non-radioactive cell-based method for the screening of SGLT1 and SGLT2 inhibitors using 1-NBDG.
Chang HC; Yang SF; Huang CC; Lin TS; Liang PH; Lin CJ; Hsu LC
Mol Biosyst; 2013 Aug; 9(8):2010-20. PubMed ID: 23657801
[TBL] [Abstract][Full Text] [Related]
8. Identification of phlorizin binding domains in sodium-glucose cotransporter family: SGLT1 as a unique model system.
Raja M; Kinne RK
Biochimie; 2015 Aug; 115():187-93. PubMed ID: 26086341
[TBL] [Abstract][Full Text] [Related]
9. Interaction of the Sodium/Glucose Cotransporter (SGLT) 2 inhibitor Canagliflozin with SGLT1 and SGLT2.
Ohgaki R; Wei L; Yamada K; Hara T; Kuriyama C; Okuda S; Ueta K; Shiotani M; Nagamori S; Kanai Y
J Pharmacol Exp Ther; 2016 Jul; 358(1):94-102. PubMed ID: 27189972
[TBL] [Abstract][Full Text] [Related]
10. Conformational dynamics of hSGLT1 during Na+/glucose cotransport.
Loo DD; Hirayama BA; Karakossian MH; Meinild AK; Wright EM
J Gen Physiol; 2006 Dec; 128(6):701-20. PubMed ID: 17130520
[TBL] [Abstract][Full Text] [Related]
11. Real-time imaging of sodium glucose transporter (SGLT1) trafficking and activity in single cells.
Ghezzi C; Calmettes G; Morand P; Ribalet B; John S
Physiol Rep; 2017 Feb; 5(3):. PubMed ID: 28193781
[TBL] [Abstract][Full Text] [Related]
12. Simulated annealing reveals the kinetic activity of SGLT1, a member of the LeuT structural family.
Longpré JP; Sasseville LJ; Lapointe JY
J Gen Physiol; 2012 Oct; 140(4):361-74. PubMed ID: 23008432
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory Effect of Tangeretin and Cardamonin on Human Intestinal SGLT1 Activity In Vitro and Blood Glucose Levels in Mice In Vivo.
Satsu H; Shibata R; Suzuki H; Kimura S; Shimizu M
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684383
[TBL] [Abstract][Full Text] [Related]
14. Structural selectivity of human SGLT inhibitors.
Hummel CS; Lu C; Liu J; Ghezzi C; Hirayama BA; Loo DD; Kepe V; Barrio JR; Wright EM
Am J Physiol Cell Physiol; 2012 Jan; 302(2):C373-82. PubMed ID: 21940664
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Structure-Activity Relationship of C-Phenyl D-Glucitol (TP0454614) Derivatives as Selective Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitors.
Kuroda S; Kobashi Y; Kawamura M; Kawabe K; Shiozawa F; Hamada M; Shimizu Y; Okumura-Kitajima L; Koretsune H; Kimura K; Yamamoto K; Kakinuma H
Chem Pharm Bull (Tokyo); 2020; 68(7):635-652. PubMed ID: 32611999
[TBL] [Abstract][Full Text] [Related]
16. Sodium-independent low-affinity D-glucose transport by human sodium/D-glucose cotransporter 1: critical role of tryptophan 561.
Kumar A; Tyagi NK; Goyal P; Pandey D; Siess W; Kinne RK
Biochemistry; 2007 Mar; 46(10):2758-66. PubMed ID: 17288452
[TBL] [Abstract][Full Text] [Related]
17. A 96-well automated method to study inhibitors of human sodium-dependent D-glucose transport.
Castaneda F; Kinne RK
Mol Cell Biochem; 2005 Dec; 280(1-2):91-8. PubMed ID: 16311909
[TBL] [Abstract][Full Text] [Related]
18. Probing binding pocket of serotonin transporter by single molecular force spectroscopy on living cells.
Wildling L; Rankl C; Haselgrübler T; Gruber HJ; Holy M; Newman AH; Zou MF; Zhu R; Freissmuth M; Sitte HH; Hinterdorfer P
J Biol Chem; 2012 Jan; 287(1):105-113. PubMed ID: 22033932
[TBL] [Abstract][Full Text] [Related]
19. Cardiac ischemia-reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity.
Yoshii A; Nagoshi T; Kashiwagi Y; Kimura H; Tanaka Y; Oi Y; Ito K; Yoshino T; Tanaka TD; Yoshimura M
Cardiovasc Diabetol; 2019 Jul; 18(1):85. PubMed ID: 31262297
[TBL] [Abstract][Full Text] [Related]
20. Intestinal Sodium Glucose Cotransporter 1 Inhibition Enhances Glucagon-Like Peptide-1 Secretion in Normal and Diabetic Rodents.
Oguma T; Nakayama K; Kuriyama C; Matsushita Y; Yoshida K; Hikida K; Obokata N; Tsuda-Tsukimoto M; Saito A; Arakawa K; Ueta K; Shiotani M
J Pharmacol Exp Ther; 2015 Sep; 354(3):279-89. PubMed ID: 26105952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
